Skip to main content

Peer Review reports

From: Chromatographic assay of recently approved co-formulation of Vonoprazan fumarate with low dose Aspirin: AGREE, Complex MoGAPI, and RGB 12-model assessments

Original Submission
15 Apr 2024 Submitted Original manuscript
15 May 2024 Reviewed Reviewer Report
18 May 2024 Reviewed Reviewer Report - Taj Muhammad Jahangir
26 Jun 2024 Author responded Author comments - Mona M. Abdel Moneim
8 Jul 2024 Reviewed Reviewer Report
13 Jul 2024 Reviewed Reviewer Report - Taj Muhammad Jahangir
15 Aug 2024 Author responded Author comments - Mona M. Abdel Moneim
Resubmission - Version 2
26 Jun 2024 Submitted Manuscript version 2
24 Sep 2024 Reviewed Reviewer Report
16 Oct 2024 Author responded Author comments - Mona M. Abdel Moneim
Resubmission - Version 3
16 Oct 2024 Submitted Manuscript version 3
31 Oct 2024 Author responded Author comments - Mona M. Abdel Moneim
Resubmission - Version 4
31 Oct 2024 Submitted Manuscript version 4
1 Nov 2024 Author responded Author comments - Mona M. Abdel Moneim
Resubmission - Version 5
1 Nov 2024 Submitted Manuscript version 5
Publishing
4 Nov 2024 Editorially accepted
16 Nov 2024 Article published 10.1186/s13065-024-01344-7

You can find further information about peer review here.

Back to article page